Heron Therapeutics, Inc. /DE/ SEC filings HRTX
Heron Therapeutics, Inc. /DE/ has 1,000 filings in SEC EDGAR's recent list, going back to Jun 2, 2011. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 16, 2025 | — |
| EFFECT | Filing | Sep 16, 2025 | — |
| CORRESP | Letter to the SEC | Sep 12, 2025 | — |
| CORRESP | Letter to the SEC | Sep 12, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2025 | — |
| 8-A12B | Filing | Aug 15, 2025 | — |
| EFFECT | Filing | Aug 31, 2023 | — |
| CORRESP | Letter to the SEC | Aug 30, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2023 | — |
| D | Filing | Aug 1, 2023 | — |
| EFFECT | Filing | Oct 18, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2021 | — |
| CORRESP | Letter to the SEC | Aug 10, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2018 | — |
| CORRESP | Letter to the SEC | Jul 30, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2018 | — |
| 8-A12B/A | Form 8-a12b/a | Jul 6, 2017 | — |
| CT ORDER | Filing | Jan 30, 2017 | — |
| CT ORDER | Filing | Dec 28, 2016 | — |
| CT ORDER | Filing | Jul 7, 2015 | — |
| EFFECT | Filing | Oct 6, 2014 | — |
| EFFECT | Filing | May 23, 2014 | — |
| CERTNAS | Auto-generated paper document | Jan 22, 2014 | — |
| 8-A12B/A | Filing | Jan 22, 2014 | — |
| EFFECT | Filing | Aug 26, 2013 | — |
| EFFECT | Filing | Sep 6, 2012 | — |
| CORRESP | Letter to the SEC | Sep 5, 2012 | — |
| CORRESP | Letter to the SEC | Aug 31, 2012 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2012 | — |
| D | Filing | Aug 10, 2012 | — |
| EFFECT | Filing | Apr 2, 2012 | — |
| EFFECT | Filing | Apr 2, 2012 | — |
| EFFECT | Filing | Aug 4, 2011 | — |
| EFFECT | Filing | Jul 29, 2011 | — |
| CORRESP | Letter to the SEC | Jul 27, 2011 | — |
| D | Filing | Jul 11, 2011 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2011 | — |
| 25-NSE | Delisting notice | Jun 3, 2011 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2011 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HRTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 818033
- Former names
- AP PHARMA INC /DE/ (until Jan 7, 2014); ADVANCED POLYMER SYSTEMS INC /DE/ (until Apr 6, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.